Azimilide—CardiOversion MaintenancE Trial–I - A-COMET-I

Description:

The goal of the trial was to evaluate treatment with azimilide compared with placebo on arrhythmia recurrence in patients with structural heart disease who had atrial fibrillation (AF) converted to sinus rhythm.